JP3154365B2 - Antibacterial resin molding - Google Patents
Antibacterial resin moldingInfo
- Publication number
- JP3154365B2 JP3154365B2 JP02550494A JP2550494A JP3154365B2 JP 3154365 B2 JP3154365 B2 JP 3154365B2 JP 02550494 A JP02550494 A JP 02550494A JP 2550494 A JP2550494 A JP 2550494A JP 3154365 B2 JP3154365 B2 JP 3154365B2
- Authority
- JP
- Japan
- Prior art keywords
- silver
- resin
- antibacterial
- complex
- silver salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、抗菌性樹脂成型体の改
良に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an improved antibacterial resin molding.
【0002】[0002]
【従来の技術】近年、合成樹脂製品が多用されるにいた
り、例えば、台所用品等のように衛生面で注意を払う必
要がある分野に用いられる場合に、合成樹脂表面の菌に
よる汚染が問題となってきている。また、建築用資材と
して使用されているコーキング材表面に菌やかびがは
え、衛生面で、あるいは外観が悪くなる等の問題が生じ
ている。その対策として、合成樹脂中に銀塩などの抗菌
剤を混入し、合成樹脂表面にその成分を溶出させて樹脂
表面の殺菌を行う方法が用いられている。2. Description of the Related Art In recent years, when synthetic resin products are frequently used, or when used in a field that requires attention to hygiene such as kitchen utensils, contamination of the surface of the synthetic resin by bacteria is a problem. It is becoming. In addition, there are problems such as fungi and mold growing on the surface of the caulking material used as a building material, resulting in hygiene or poor appearance. As a countermeasure, a method has been used in which an antibacterial agent such as a silver salt is mixed into a synthetic resin and the component is eluted on the surface of the synthetic resin to sterilize the resin surface.
【0003】[0003]
【発明が解決しようとする課題】抗菌剤として銀塩を用
い、これを成型体母材樹脂中に分散させる場合、銀塩の
適量については、明らかにされていない。銀塩の含量が
大きいと、光などにより容易に銀に還元され、抗菌剤と
して機能しなくなる。また、銀塩の含量が少ないと抗菌
効果が得られない。さらに、用いる銀塩の溶解度によっ
ても抗菌効果が異なったものとなる。従って本発明は、
樹脂成型体が使用される際の周囲液体中で抗菌剤として
働く有効な銀量を明らかにし、抗菌作用を発揮する樹脂
成型体を提供するものである。When a silver salt is used as an antibacterial agent and is dispersed in a base resin of a molded product, an appropriate amount of the silver salt is not disclosed. When the content of the silver salt is large, it is easily reduced to silver by light or the like, and does not function as an antibacterial agent. On the other hand, if the content of silver salt is small, the antibacterial effect cannot be obtained. Furthermore, the antibacterial effect varies depending on the solubility of the silver salt used. Therefore, the present invention
An object of the present invention is to clarify an effective amount of silver acting as an antibacterial agent in a surrounding liquid when a resin molded article is used, and to provide a resin molded article exhibiting an antibacterial action.
【0004】[0004]
【課題を解決するための手段】本発明の抗菌性樹脂成型
体は、銀塩を分散させた樹脂成型体であって、この成型
体に接する周囲液体中の銀塩の濃度が、銀量に換算し
て、1ppb以上、2000ppb以下となるような量
の銀塩を含むものである。Antibacterial resin molded body of the present invention, in order to solve the problem] is a resin molded body obtained by dispersing the silver salt, the concentration of the silver salt of the ambient liquid in contact with the molded body, the silver amount It contains silver salt in such an amount as to be 1 ppb or more and 2000 ppb or less in conversion.
【0005】前記抗菌性樹脂成型体は、具体的には、母
材樹脂がABS樹脂であり、前記銀塩がシリカゲルに担
持されたチオスルファト銀錯塩であり、かつ前記銀塩を
銀量に換算して1×10-5wt%以上、1×10-3wt
%以下母材樹脂中に含んでいる。また、母材樹脂がオレ
フィン系樹脂であり、前記銀塩がシリカゲルに担持され
たチオスルファト銀錯塩であり、かつ前記銀塩を銀量に
換算して1×10-4wt%以上、2×10-3wt%以下
母材樹脂中に含んでいる。 Specifically, the antibacterial resin molded article has a matrix resin of an ABS resin, a silver salt of a thiosulfatosilver complex supported on silica gel, and converts the silver salt into a silver amount. 1 × 10 −5 wt% or more and 1 × 10 −3 wt%
% Or less in the base resin. Further , the base resin is an olefin resin, the silver salt is a silver thiosulfato complex salt supported on silica gel, and the silver salt is 1 × 10 −4 wt% or more in terms of silver and 2 × 10 −4 wt% or more. -3 wt% or less contained in base resin.
【0006】[0006]
【作用】従来、銀塩を水などの液体中に溶解させた場
合、濃度が高い方が抗菌効果が大きいと考えられてい
た。本発明は、銀塩の濃度が限度以下の低濃度の場合の
みでなく、ある程度の高濃度の場合にも抗菌効果を発揮
しないことを見出したことに基づくものである。すなわ
ち、上記のように、液体中における銀塩の濃度が1pp
b以上、2000ppb以下の場合に抗菌効果を発揮す
る。なお、約70ppm以上においても抗菌効果が得ら
れる。しかし、そのような高濃度を得るには、母材樹脂
中の銀塩の含量を増やさねばならず、そうすると光など
により還元される量が増し、不経済である。In the past, when a silver salt was dissolved in a liquid such as water, it was considered that the higher the concentration, the greater the antibacterial effect. The present invention is based on the finding that the antibacterial effect is not exhibited not only when the concentration of the silver salt is lower than the limit but also when the concentration is high to some extent. That is, as described above, the concentration of the silver salt in the liquid is 1 pp.
The antibacterial effect is exhibited in the case of b or more and 2000 ppb or less. Note that an antibacterial effect can be obtained even at about 70 ppm or more. However, in order to obtain such a high concentration, the content of the silver salt in the base resin must be increased, which increases the amount reduced by light or the like, which is uneconomical.
【0007】銀塩としては、各種のものが知られてお
り、本発明においてはそれらを用いることもできるが、
以下に説明するチオスルファト銀錯塩は、塩素イオンを
含む水道水に接しても白濁することなく、抗菌作用を発
揮するので、台所まわりの樹脂成型体に用いるのに好都
合である。Various silver salts are known, and they can be used in the present invention.
The silver thiosulfato complex described below exhibits an antibacterial effect without becoming clouded even when it comes in contact with tap water containing chloride ions, and is therefore convenient for use in resin moldings around kitchens.
【0008】[0008]
【実施例】以下に、本発明で用いる抗菌剤の好ましい製
造方法を説明する。先ず、原料のCH3COOAgは溶
解度が小さいので、溶解度に近い7.7g/lを60℃
以下の温度で純水に溶解する。この溶解工程は、60℃
を超える温度に加熱するとCH3COOAgが分解する
ので、60℃以下室温の範囲が好ましい。次に、チオス
ルファト錯塩形成工程では、K2SO3:CH3COOA
g=2.7g:1gの割合でK2SO3を先ず添加し、充
分溶解させた後にK2S2O3:CH3COOAg=6.6
g:1gの割合でK2S2O3を添加溶解させる。この時
の溶解工程は40℃〜室温の温度範囲が好ましい。The preferred method for producing the antibacterial agent used in the present invention will be described below. First, since CH 3 COOAg as a raw material has low solubility, 7.7 g / l close to the solubility is converted to 60 ° C.
Dissolve in pure water at the following temperatures. This dissolving step is performed at 60 ° C.
When heated to a temperature exceeding 60 ° C., CH 3 COOAg is decomposed. Next, in the thiosulfato complex salt forming step, K 2 SO 3 : CH 3 COOA
g = 2.7 g: K 2 SO 3 was first added at a ratio of 1 g, and after sufficient dissolution, K 2 S 2 O 3 : CH 3 COOAg = 6.6.
g: K 2 S 2 O 3 is added and dissolved at a ratio of 1 g. The melting step at this time is preferably in a temperature range of 40 ° C. to room temperature.
【0009】次に吸着工程は、平衡水分量が10%以下
の含水無晶形二酸化ケイ素、いわゆるシリカゲルの所望
の粒度、好ましくは1〜100μmのものを担体に用
い、チオスルファト銀錯塩を担体に所望の濃度になるよ
う充分に吸着含浸させる。ここでは、シリカゲルとして
シオノギ製薬(株)のカープレックスCS−5(平均粒
径2.3μm)を担体として用いた。この工程は、40
℃〜室温が好ましい。次に乾燥工程であるが、チオスル
ファト銀錯塩が分解しないように、圧力は常圧ないし1
0-2Torr、温度は40〜120℃とするのが好まし
い。次に、ゾルゲル法により、チオスルファト銀錯塩を
担持した担体の表面に外殻被覆層を形成する。この被覆
層はチオスルファト銀錯塩の抗菌性やウィルス抑止性の
薬治効果の持続時間を調整する役割を有する。すなわ
ち、被覆層の面積や厚さにより薬治効果の持続性の制御
を可能にする。Next, in the adsorption step, a water-containing amorphous silicon dioxide having an equilibrium water content of 10% or less, so-called silica gel having a desired particle size, preferably 1 to 100 μm, is used as a carrier, and a silver thiosulfato complex is used as a carrier. Adsorb and impregnate sufficiently to obtain a concentration. Here, Carplex CS-5 (average particle diameter: 2.3 μm) manufactured by Shionogi Pharmaceutical Co., Ltd. was used as the silica gel. This step involves 40
C. to room temperature are preferred. Next, in the drying step, the pressure is from normal pressure to 1 to prevent decomposition of the silver thiosulfato complex.
It is preferable that the temperature is 0 -2 Torr and the temperature is 40 to 120 ° C. Next, an outer shell coating layer is formed on the surface of the carrier supporting the silver thiosulfato complex by a sol-gel method. This coating layer has a role of adjusting the duration of the antibacterial and virus-suppressing pharmacological effects of the silver thiosulfato complex. That is, it is possible to control the persistence of the drug treatment effect by the area and thickness of the coating layer.
【0010】ここに用いるアルコキシシランおよびアル
コールは、そのアルキル基の炭素数1〜4のものが好ま
しい。ここでは標準処方のテトラエトキシシラン(CH
3CH2O)4Siとエチルアルコールを用いる。各々の
1mlを混合した液に、前記のチオスルファト銀錯塩を
担持したシリカゲル粒子を1gの割合で加え、よく混合
した後、約0.2mlの純水を滴下することにより、テ
トラエトキシシランを加水分解した二酸化ケイ素による
被覆層を形成する。空気中の湿気を吸収することにより
反応はさらに進む。約60℃未満の温度で加熱すると反
応が早く進む。次に乾燥工程は、チオスルファト銀錯塩
が分解しないように、圧力は760mmHg〜10-2T
orr、温度は120℃〜40℃が好ましい。以上のよ
うにして、抗菌剤を得る。The alkoxysilane and alcohol used here preferably have an alkyl group having 1 to 4 carbon atoms. Here, the standard formulation of tetraethoxysilane (CH
3 CH 2 O) 4 Si and ethyl alcohol are used. 1 g of the silica gel particles supporting the above silver thiosulfato complex were added to a mixture of 1 ml of each, and after mixing well, about 0.2 ml of pure water was added dropwise to hydrolyze the tetraethoxysilane. To form a coating layer of silicon dioxide. The reaction proceeds further by absorbing the moisture in the air. Heating at a temperature less than about 60 ° C. accelerates the reaction. Next, in the drying step, the pressure is set to 760 mmHg to 10 -2 T so that the silver thiosulfato complex is not decomposed.
The orr and the temperature are preferably from 120C to 40C. As described above, an antibacterial agent is obtained.
【0011】樹脂成型に際して、ステアリン酸カルシウ
ムなどの炭化水素またはその誘導体を樹脂特性改良剤と
してしばしば添加される。これらは菌の増殖源になるば
かりでなく多量に添加されると上記のような銀錯塩を担
持したシリカゲルの表面を被覆して抗菌効果を妨げるこ
ととなる。従って、これらの樹脂特性改良剤を加える場
合は、その添加割合は母材樹脂の1wt%以下に制限す
ることが好ましい。At the time of resin molding, a hydrocarbon such as calcium stearate or a derivative thereof is often added as a resin property improving agent. When these are added in a large amount as well as a growth source of the bacterium, they cover the surface of the silica gel supporting the above-mentioned silver complex salt and hinder the antibacterial effect. Therefore, when adding these resin property improvers, it is preferable to limit the addition ratio to 1 wt% or less of the base resin.
【0012】[実施例1]上記のようにして銀量に換算
して3wt%のチオスルファト銀錯塩を含む抗菌剤を作
製した。この抗菌剤を各種の割合で含む水分散液を調製
し、それに黄色ブドウ球菌を加え、18時間培養後、生
存菌数の測定にかえ培養液の濁度を測定して抗菌効果を
判定した。抗菌剤の銀量に換算した濃度と抗菌効果の有
無(有;○印、無;×印)の関係を表1に示す。表1か
ら明らかなように、銀量に換算した銀塩の濃度1ppb
以上で抗菌効果を有するが、2ppm以上60ppm程
度までは抗菌効果が得られない。Example 1 An antibacterial agent containing 3% by weight of silver thiosulfato complex in terms of silver was prepared as described above. An aqueous dispersion containing this antibacterial agent in various ratios was prepared, Staphylococcus aureus was added thereto, and after culturing for 18 hours, the turbidity of the culture solution was measured instead of the number of viable bacteria to determine the antibacterial effect. Table 1 shows the relationship between the concentration of the antibacterial agent in terms of the amount of silver and the presence or absence of the antibacterial effect (presence; 印, no; ×). As is clear from Table 1, the concentration of silver salt in terms of silver amount is 1 ppb.
Although the antibacterial effect is obtained as described above, the antibacterial effect cannot be obtained at 2 ppm or more to about 60 ppm.
【0013】[0013]
【表1】 [Table 1]
【0014】[実施例2]実施例1と同様の抗菌剤をA
BS樹脂およびポリプロピレン樹脂にそれぞれ0.01
0〜7.0wt%混練し、これらを厚さ2mmのテスト
プレートに成型した。これらのテストプレートについて
ブドウ球菌を用いた滴下法による実験をし、実施例1と
同様にして抗菌性を評価した。その結果を表2に示す。
樹脂成型体中の抗菌剤についても、最適濃度が存在する
ことがわかる。Example 2 The same antibacterial agent as in Example 1 was used as A
0.01 for BS resin and polypropylene resin respectively
The mixture was kneaded at 0 to 7.0 wt% and molded into a test plate having a thickness of 2 mm. An experiment was conducted on these test plates by a dropping method using staphylococci, and the antibacterial properties were evaluated in the same manner as in Example 1. Table 2 shows the results.
It can be seen that there is an optimum concentration of the antibacterial agent in the resin molding.
【0015】[0015]
【表2】 [Table 2]
【0016】[0016]
【発明の効果】本発明によれば、良好な抗菌性能を発揮
する樹脂成型体が得られる。According to the present invention, a resin molded product exhibiting good antibacterial performance can be obtained.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 岡 弘章 大阪府門真市大字門真1006番地 松下電 器産業株式会社内 (72)発明者 西野 敦 大阪府門真市大字門真1006番地 松下電 器産業株式会社内 (56)参考文献 特開 平6−73196(JP,A) 特開 平2−292201(JP,A) 特開 平3−84066(JP,A) 特開 平5−17617(JP,A) 特開 平5−201817(JP,A) (58)調査した分野(Int.Cl.7,DB名) C08L 1/00 - 101/16 C08K 3/00 - 13/08 A01N 59/16 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Hiroaki Oka 1006 Kadoma Kadoma, Osaka Prefecture Matsushita Electric Industrial Co., Ltd. (56) References JP-A-6-73196 (JP, A) JP-A-2-292201 (JP, A) JP-A-3-84066 (JP, A) JP-A-5-17617 (JP, A) JP-A-5-201817 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) C08L 1/00-101/16 C08K 3/00-13/08 A01N 59/16
Claims (2)
銀錯塩を分散させたABS樹脂からなる樹脂成型体であ
って、銀量に換算して1×10-5wt%以上1×10-3
wt%以下の前記銀錯塩を前記ABS樹脂中に含む抗菌
性樹脂成型体。1. A consists supported silver thiosulfate complex ABS resin dispersed with the sheet Rikageru resin molded body der
I, in terms of silver amount 1 × 10 -5 wt% or more 1 × 10 -3
including antibacterial resin molded body wt% or less of the silver complex in the ABS resin.
銀錯塩を分散させたオレフィン系樹脂からなる樹脂成型
体であって、銀量に換算して1×10-4wt%以上2×
10-3wt%以下の前記銀錯塩を前記オレフィン系樹脂
中に含む抗菌性樹脂成型体。2. A consists supported silver thiosulfate complex salt olefin resin dispersed in shea Rikageru resin molding
A body, 2 × 1 × 10 -4 wt % or more in terms of silver amount
Including antibacterial resin molded body in a 10 -3 wt% or less of the silver complex in the olefin resin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02550494A JP3154365B2 (en) | 1994-02-23 | 1994-02-23 | Antibacterial resin molding |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02550494A JP3154365B2 (en) | 1994-02-23 | 1994-02-23 | Antibacterial resin molding |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07233279A JPH07233279A (en) | 1995-09-05 |
JP3154365B2 true JP3154365B2 (en) | 2001-04-09 |
Family
ID=12167905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP02550494A Expired - Fee Related JP3154365B2 (en) | 1994-02-23 | 1994-02-23 | Antibacterial resin molding |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3154365B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7579396B2 (en) | 2007-01-31 | 2009-08-25 | Eastman Kodak Company | Polymer composite |
US8158140B2 (en) | 2008-10-14 | 2012-04-17 | Eastman Kodak Company | Silver polyamide composite |
-
1994
- 1994-02-23 JP JP02550494A patent/JP3154365B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH07233279A (en) | 1995-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5429819A (en) | Antiviral composition | |
US6294183B1 (en) | Antimicrobial resin composition and antimicrobial resin molded article comprising same | |
JPH08253690A (en) | Antimicrobial resin composition | |
JPH02292201A (en) | Antibacterial silica gel and antibacterial resin | |
JP3154365B2 (en) | Antibacterial resin molding | |
US5651978A (en) | Silver thiosulfate silica gel antibacterial compositions | |
JPH0647625B2 (en) | Synthetic resin molding | |
JP2912142B2 (en) | Anti-membrane viral composition and method for producing the same | |
JP3347875B2 (en) | Antibacterial antiviral antifungal agent and its complex | |
JPH08113729A (en) | Antimicrobial composition and production thereof | |
JP2559126B2 (en) | Weather resistant antibacterial zeolite composition | |
JPH1160804A (en) | Antibacterial resin composition and molded article using same | |
CN111569951A (en) | Composition for removing formaldehyde and peculiar smell of furniture | |
JPH09131389A (en) | Controlled release antibacterial material, antibacterial solution, antibacterial spray | |
JPH05140331A (en) | Plastic product and its production | |
JPH0628728B2 (en) | Antibacterial water-absorbent molding | |
JP3191608B2 (en) | Composition for antibacterial deodorant spray | |
JP2965459B2 (en) | Antimicrobial composite and method for producing the same | |
JPH08169981A (en) | Antibacterial resin composition | |
JPH061706A (en) | Production of antimicrobial agent | |
JP3154371B2 (en) | Manufacturing method of antibacterial material | |
JPH08259413A (en) | Antibacterial and mildewproofing composition, and its production | |
JP3350212B2 (en) | Antimicrobial composition | |
JPH07138116A (en) | Antimicrobial coating film | |
JP2991573B2 (en) | Antimicrobial composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080202 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090202 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100202 Year of fee payment: 9 |
|
LAPS | Cancellation because of no payment of annual fees |